Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04246632 · ClinicalTrials.gov registry record · NA

CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)

A NA study of Colonoscopy, sponsored by Capso Vision.

Completed
Registry status
NA
Development phase
112
Enrollment target
3
Study locations

NCT04246632 is a NA study of Colonoscopy that has completed, run by Capso Vision. The registered enrollment target is 112 participants, below the 496-participant average among 20 other Colonoscopy trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04246632, a NA study of Colonoscopy, has completed, sponsored by Capso Vision.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
3
Study locations

Study Summary

This non-significant risk pilot study is designed to evaluate safety and performance of the CapsoCam® Colon capsule endoscope in patients who meet the eligibility criteria and are scheduled for colonoscopy.

Conditions Studied

Interventions

  • DEVICE CapsoCam Colon Capsule Endoscopy

Study Locations (3)

California

  • Silicon Valley Research Institute, Inc. - San Jose
  • CapsoVision Research Clinic - Saratoga

Michigan

  • West Michigan Clinical Research Center - Wyoming

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2020-01-25
Est. Completion 2021-03-15
Phase NA

Sponsor

Capso Vision

6 total trials

What the Registry Record Tells You About NCT04246632

The ClinicalTrials.gov registry entry for NCT04246632 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 496-participant average among 20 other Colonoscopy trials with a reported enrollment target (77% lower). The listed sponsor is Capso Vision, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 1 intervention - of which CapsoCam Colon Capsule Endoscopy is the first listed.

NCT04246632 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Michigan.

Frequently Asked Questions

What is clinical trial NCT04246632 about?

NCT04246632 is a clinical study titled "CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)". This non-significant risk pilot study is designed to evaluate safety and performance of the CapsoCam® Colon capsule endoscope in patients who meet the eligibility criteria and are scheduled for colonoscopy.

What is the current status of trial NCT04246632?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2020-01-25. Estimated completion is 2021-03-15.

What conditions does trial NCT04246632 study?

This clinical trial studies the following conditions: Colonoscopy.

What interventions are being tested in trial NCT04246632?

The interventions under investigation include: CapsoCam Colon Capsule Endoscopy (DEVICE).

Who is sponsoring clinical trial NCT04246632?

This trial is sponsored by Capso Vision, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04246632 being conducted?

This trial has 3 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonoscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.